The U.S. Department of Transportation published a final rule April 23 that makes technical corrections to regulations governing drug testing for safety-sensitive employees to ensure consistency with recent amendments made to DOT’s “Procedures for Transportation Workplace Drug and Alcohol Testing Programs,” which recently added requirements for testing for oxycodone, oxymorphone, hydrocodone and hydromorphone.
According to the release from DOT, the new changes to the department’s regulations make it necessary to refer to these substances, as well as morphine, 6-acetylmorphine and codeine by the term “opioids” rather than “opiates.”
This final rule amends the term in the FAA, FTA and PHMSA regulations to ensure that all DOT drug testing rules are consistent with one another and the mandatory guidelines for the testing program.
Click here to read more about this final rule.
Related News
- Value of Unions
- New Mass. Law Protects SMART-TD Transit Members
- Bills Mount After Texas Conductor Loses a Leg
- 2026 Railroad Retirement and Unemployment Insurance Tax Changes
- SMART-TD Members on UP Properties Ratify Five-Year Agreement
- Railroader’s Son to Perform at Carnegie Hall
- Union Members Head to College Thanks to Tuition Benefit
- Rail Trespassing and Suicide Fatalities Up 70%
- New Jersey Governor-Elect Sherrill Names SMART-TD’s Ron Sabol to Transition Team
- Help the McLucas Family After Fire Destroys Their Home